Back to search

Article

Mechanism of Sanliangsan Lipid-Lowering in treating hyperlipidemia: insights from network pharmacology and molecular docking

2025-09-28

Abstract excerpt

Abstract   Background and Objective   This study used network pharmacology to identify active ingredients, key targets, and signaling pathways of Sanliangsan Lipid-Lowering (SLL) for hyperlipidemia (HLP), and clarify its lipid-lowering material basis and mechanism.       Methods   SLL active ingredients were retrieved from TCMSP, with corresponding targets obtained from Uniprot (duplicates excluded). Cytoscape co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c97d332-ebef-5e02-ac46-8120fd65797e
DOI
10.1101/2025.09.25.678651
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mechanism of Sanliangsan Lipid-Lowering in treating hyperlipidemia: insights from network pharmacology and molecular dockingDOI 10.1101/2025.09.25.678651
Select a neighboring publication to make it the new centre.